Valeant Pharmaceuticals International and Turing Pharmaceuticals are the focus of two probes in Congress seeking to examine why the companies raised the prices of medications sharply after acquiring them.

The US has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids.